As of June 13, 2025, ARCA Biopharma Inc (ABIO) reports a Net Margin of -26.25%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Comparing ARCA Biopharma Inc's Net Margin to Peers
To better understand ARCA Biopharma Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| ARCA Biopharma Inc (ABIO) | -26.25% |
| Forward Pharma A/S (FWP) | 73.37% |
| Regeneron Pharmaceuticals Inc (REGN) | 31.07% |
| Amgen Inc (AMGN) | 12.24% |
| Abbvie Inc (ABBV) | 7.59% |
| Gilead Sciences Inc (GILD) | 1.67% |
Compared to its competitors, ARCA Biopharma Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.